CLX vs CRVO · P/E 15, rev $7.10B vs $28.8M cap
The Clorox Company (CLX) versus CervoMed Inc. (CRVO) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
CervoMed Inc. (CRVO) is a biotechnology company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported CRVO revenue for 2026-06-30 was $0. Net income was -$14.5M. CRVO currently screens at market cap $28.8M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. CRVO currently screens at market cap $28.8M.
Not investment advice. Open the CLX and CRVO stock pages for the full models.
Not investment advice.